Search Results - "Khatri, Ismat"

Refine Results
  1. 1

    Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling by Tang, Michael, Diao, Jun, Gu, Hongtao, Khatri, Ismat, Zhao, Jun, Cattral, Mark S.

    Published in Cell reports (Cambridge) (29-12-2015)
    “…Although dendritic cell (DC) dysfunction in cancer is a well-recognized consequence of cancer-associated inflammation that contributes to immune evasion, the…”
    Get full text
    Journal Article
  2. 2

    Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model by Curry, Anna, Khatri, Ismat, Kos, Olha, Zhu, Fang, Gorczynski, Reginald

    Published in PloS one (24-02-2017)
    “…Cell-surface CD200 expression by mouse EMT6 breast tumor cells increased primary tumor growth and metastasis to the draining lymph nodes (DLN) in normal (WT)…”
    Get full text
    Journal Article
  3. 3

    Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells by Fang, Karen Kai-Lin, Lee, Jongbok, Khatri, Ismat, Zhang, Li

    Published in Journal for immunotherapy of cancer (01-09-2023)
    “…Background Patients with relapsed/refractory T-cell malignancies have limited treatment options. The use of chimeric antigen receptor (CAR)-T cell therapy for…”
    Get full text
    Journal Article
  4. 4

    Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy by Gorczynski, Reginald M, Chen, Zhiqi, Erin, Nuray, Khatri, Ismat, Podnos, Anna

    Published in PloS one (19-11-2014)
    “…We have compared cure from local/metastatic tumor growth in BALB/c mice receiving EMT6 or the poorly immunogenic, highly metastatic 4THM, breast cancer cells…”
    Get full text
    Journal Article
  5. 5

    Characterization of CD200 Ectodomain Shedding by Wong, Karrie K, Zhu, Fang, Khatri, Ismat, Huo, Qiang, Spaner, David E, Gorczynski, Reginald M

    Published in PloS one (25-04-2016)
    “…We have previously reported the existence of a soluble form of CD200 (sCD200) in human plasma, and found sCD200 to be elevated in the plasma of Chronic…”
    Get full text
    Journal Article
  6. 6

    Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression by Twito, Tal, Chen, Zhiqi, Khatri, Ismat, Wong, Karrie, Spaner, David, Gorczynski, Reg

    Published in Leukemia research (01-07-2013)
    “…Abstract CD200, a membrane glycoprotein of the immunoglobulin superfamily, is overexpressed in CLL. Soluble in serum CD200 (sCD200) is correlated with poor…”
    Get full text
    Journal Article
  7. 7

    A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo by Prodeus, Aaron, Sparkes, Amanda, Fischer, Nicholas W., Cydzik, Marzena, Huang, Eric, Khatri, Ismat, Young, Ashley, Woo, Lindsay, Chow, Chung Wai, Gorczynski, Reginald, Gariépy, Jean

    Published in Molecular therapy. Nucleic acids (07-09-2018)
    “…Functional aptamers displaying agonistic or antagonistic properties are showing great promise as modulators of immune responses. Here, we report the…”
    Get full text
    Journal Article
  8. 8

    The role of CD200 in immunity to B cell lymphoma by Wong, Karrie K., Khatri, Ismat, Shaha, Suchinta, Spaner, David E., Gorczynski, Reginald M.

    Published in Journal of leukocyte biology (01-08-2010)
    “…CD200 expression on lymphoma/CLL cells, or in CLL serum, suppresses immunity yet is overcome by neutralizing antibody, siRNAs, or absorption of CD200 from…”
    Get full text
    Journal Article
  9. 9

    Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival by Prodeus, Aaron, Cydzik, Marzena, Abdul-Wahid, Aws, Huang, Eric, Khatri, Ismat, Gorczynski, Reginald, Gariépy, Jean

    Published in Molecular therapy. Nucleic acids (01-08-2014)
    “…CD200R1 expressed on the surface of myeloid and lymphoid cells delivers immune inhibitory signals to modulate inflammation when engaged with its ligand CD200…”
    Get full text
    Journal Article
  10. 10

    Peptides of CD200 Modulate LPS-Induced TNF-α Induction and Mortality In Vivo by Gorczynski, Reg, M.D., Ph.D, Boudakov, Ivo, Ph.D, Khatri, Ismat, Ph.D

    Published in The Journal of surgical research (01-03-2008)
    “…Interaction of the ubiquitously expressed molecule CD200 with its receptor(s) CD200R, expressed on cells of myeloid and lymphoid origin, delivers…”
    Get full text
    Journal Article
  11. 11

    Identification of an Expressed Truncated Form of CD200, CD200tr, which is a Physiologic Antagonist of CD200-Induced Suppression by ZHIQI CHEN, CHEN, Dang-Xiao, YU KAI, KHATRI, Ismat, LAMPTEY, Brent, GORCZYNSKI, Reginald M

    Published in Transplantation (27-10-2008)
    “…Earlier studies have indicated that cell surface expressed CD200, or a soluble form of this molecule, can induce immunosuppression in a number of biological…”
    Get full text
    Journal Article
  12. 12

    N-linked oligosaccharides play a role in disulphide-dependent dimerization of intestinal mucin Muc2 by Bell, Sherilyn L, Xu, Gongqiao, Khatri, Ismat A, Wang, Rongquan, Rahman, Sameera, Forstner, Janet F

    Published in Biochemical journal (01-08-2003)
    “…Within the C-terminal domain of many secretory mucins is a 'cystine knot' (CK), which is needed for dimer formation in the endoplasmic reticulum. Previous…”
    Get full text
    Journal Article
  13. 13

    C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components by Wang, Rongquan, Khatri, Ismat A, Forstner, Janet F

    Published in Biochemical journal (01-09-2002)
    “…Although human MUC3 and rodent Muc3 are both membrane-associated intestinal mucins, the present study has explored the possibility that rodent Muc3 might exist…”
    Get full text
    Journal Article
  14. 14

    SEA (sea-urchin sperm protein, enterokinase and agrin)-module cleavage, association of fragments and membrane targeting of rat intestinal mucin Muc3 by Khatri, Ismat A, Wang, Rongquan, Forstner, Janet F

    Published in Biochemical journal (15-05-2003)
    “…In a previous study we showed, by transient expression studies in COS-1 cells, that the C-terminal domain of rat intestinal membrane mucin Muc3 was cleaved…”
    Get full text
    Journal Article
  15. 15

    A comparison of the biological properties of small molecular weight agonists and antagonists of CD200:CD200R interactions by Gorczynski, Reg, Boudakov, Ivo, Khatri, Ismat

    “…Our laboratory and others have documented in some detail the immunological consequences which follow from interaction of the ubiquitously expressed molecule…”
    Get more information
    Journal Article
  16. 16

    Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients by KHATRI, Ismat A, RAMAKRISHNAN BHASKAR, K, LAMONT, J. Thomas, UMADEVI SAJJAN, S, HO, Catherine K. Y, FORSTNER, Janet

    Published in Pediatric research (01-04-2003)
    “…Cystic fibrosis (CF) patients develop chronic lung infections associated with airway obstruction by viscous and insoluble mucus secretions. Although mucus…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Evidence for a second peptide cleavage in the C-terminal domain of rodent intestinal mucin Muc3 by Khatri, Ismat A, Wang, Rongquan, Forstner, Janet F

    Published in Biochemical journal (15-02-2004)
    “…Rat intestinal mucin Muc3 (rMuc3), like its human homologue (MUC3) and several other membrane mucins, contains a C-terminally located SEA (sea urchin sperm…”
    Get full text
    Journal Article
  19. 19

    Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities by Vasic, Daniel, Lee, Jong Bok, Leung, Yuki, Khatri, Ismat, Na, Yoosu, Abate-Daga, Daniel, Zhang, Li

    Published in Science immunology (22-04-2022)
    “…The development of autologous chimeric antigen receptor T (CAR-T) cell therapies has revolutionized cancer treatment. Nevertheless, the delivery of CAR-T cell…”
    Get more information
    Journal Article
  20. 20

    Immunization of CD200R1KO mice post surgical resection of EMT6 breast cancer leads to long-term (>1year) cure of metastatic tumor growth (TUM2P.1022) by Gorczynski, R., Khatri, Ismat, Podnos, Anna

    Published in The Journal of immunology (1950) (01-05-2015)
    “…Abstract Attenuated expression of CD200 decreases local tumor growth and metastasis in immunocompetent animals. We explored the ability to cure BALB/c CD200KO…”
    Get full text
    Journal Article